Madrigal Pharmaceuticals Inc (MDGL)

CapEx to Revenue

1.17%

Quarterly · Period ending:

MDGL logo

MDGL CapEx to Revenue

Latest reported1.17%
MDGL Quarterly CapEx/Revenue (0.00% → 1.17%)
High-resolution chart · PNG

MDGL capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
1.1676%
1.2363%
0.1215%
0.2983%
0%
0%
0.1887%
1.2529%
35.0526%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
1.1295%
0%
0%
100%
11.1598%
15.8053%
2.5849%
0.8749%
0.6688%
2.0692%
1.1607%
0%
1.2821%
0.0238%
2.172%
8.4701%
117.7673%
34.9057%
44.5441%
29.5217%
116.5545%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.